上QQ阅读APP看书，第一时间看更新
参 考 文 献
1.Dakshinamurti S.Pathophysiologic mechanisms of persistent pulmonary hypertension of the newborn.Pediatr pulmonol，2005，39：492-503.
2.Hernandez-Diaz S，Van Marter LJ，Werler M，et al.Risk factors for persistent pulmonary hypertension of the newborn.Pediatrics，2007，120（2）：272-282.
3.Ichinose F，Roberts JD，Zapol WM.Inhaled nitric oxide：A selective pulmonary vasodilator： Current uses and therapeutic potential.Circulation，2004，109： 3106-3111.
4.Ostrea EM，Villanueva-Uy ET，Natarajan G，et al.Persistent pulmonary hypertension of the newborn.Pediatr Drugs，2006，8：179-188.
5.Sokol GM，Ehrenkanz RA.Inhaled nitric oxide therapy in neonatal hypoxic respiratory failure： Insights beyond primary outcome.Semin Perinatol，2003，27：311-319.
6.Travadi JN，Petole SK.Phosphdisterase inhibitors for Inhaled nitric oxide of the newborn： A review.Pediatr Pulmonol，2003，36：529-535.
7.Bartlett RH.Extracorporeal life support： History and new direction.ASAIO J，2005，51（5）：487-489.
8.McNally H，Bennett CC，Elbourne D，et al.UK Collaborative ECMO Trial Group.United Kingdom collaborative randomized trial of neonatal extracorporeal membrane oxygenation： Follow-up to age 7years.Pediatrics，2006，117（5）： 845-854.
9.Annich GM，Lynch WR，Maclaren G，et al.ECMO： Extracorporeal cardiopulmonary support in critical care.4 rd ed.Michigan： Extracorporeal cardiopulmonary support Ann Arbor Michigan ，2012.
10.Cloherty John P，Eichenwald Eric C，Stark Ann R.Manual of Neonatal Care.5 th ed.Philadelphia： Lippincott Williams&Wilkins，2013.
11.Peetsold MG，Heij HA，Kneepkens CM，et al.The longterm follow-up of patients with a congenital diaphragmatic hernia： a broad spectrum of morbidity.Pediatr Surg Int.，2009 ，25（1）：1-17.
12.Karimova A，Brown K，Ridout D，et al.Neonatal extracorporeal membrane oxygenation： practice patterns and predictors of outcome in the UK.Arch Dis Child Fetal Neonatal Ed，2009 ，94（2）：F129-132.
13.Peterson AL，Deatsman S，Frommelt MA.Correlation of echocardiographic markers and therapy in persistent pulmonary hypertension of the newborn.Pediatr Cardiol，2009 ，30（2）：160-165.
14.Finer NN，Barrington KJ.Nitric oxide for respiratory failure in infants born at or near term.Cochrane Database Syst Rev，2006，18（4）：CD000399.
15.Goissen C，Ghyselen L，Tourneux P，et al.Persistent pulmonary hypertension of the newborn with transposition of the great arteries： successful treatment with bosentan.1：Eur J Pediatr，2008，167（4）：437-440.
16.Ho JJ，Rasa G.Magnesium sulfate for persistent pulmonary hypertension of the newborn.Cochrane Database Syst Rev，2007，18（3）：CD005588.
17.Ford JW.Neonatal ECMO： Current controversies and trends.Neonatal Netw，2006，25（4）：229-238.
18.Juliana AE，Abbad FC.Severe persistent pulmonary hypertension of the newborn in a setting where limited resources exclude the use of inhaled nitric oxide：successful treatment with sildenafil.Eur J Pediatr，2005，164（10）：626-629.
19.Mugford M，Elbourne D，Field D.Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants.Cochrane Database Syst Rev，2008 ，16（3）：CD001340.
20.Donn SM，Sinha SK.Manual of Neonatal Respiratory Care.4 rd.London；New Youk Dordrecht Heidelberg London，2012.
21.Billie Lou Shout，Lisa Williams.ECMO Specialist Training Manual 3 rd.Michigan： Extracorporeal cardiopulmonary support Ann Arbor Michigan，2010.